RESUMO
Objective:To investigate the effects of Seroxat on Essential Hypertensive subjects with anxiety and depression and to explore its clinical implications. Methods:After evaluating 77 cases with essential hypertension by SDS and SAS, the subjects with positive results who were followed for 12 weeks from baseline assessments were randomly divided into experimental group (routine treatment and Seroxat) and control group(only routine treatment) and the subjects with negative results were regarded as non-anxiety and non-depression group. The time of the amelioration of symptom , the duration of hospitalization, the drug costs and clinical outcome were compared between 3 groups. The scores of SDS\SAS\QOL were compared within and between the experimental and control group.Results: In experimental groups and non-anxiety and non-depression groups, the time of the amelioration of symptom and the duration of hospitalization were shorter, the drug costs were less and clinical outcome was significantly better than those of control group. The scores of SDS and SAS in experimental groups were significantly lower and the scores of 3 items of QOL were significantly higher than those of control groups.Conclusion:The drug therapy on anxiety and depression could shorter the time of the amelioration of symptom, the duration of hospitalization, decrease the drug costs in hospital, significantly improve clinical outcome, and also lower the degree of psychological obstacle, improve quality of life of essential hypertension patients.